These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17389731)

  • 1. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.
    Ahmed A
    J Gerontol A Biol Sci Med Sci; 2007 Mar; 62(3):323-9. PubMed ID: 17389731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
    Ahmed A; Pitt B; Rahimtoola SH; Waagstein F; White M; Love TE; Braunwald E
    Int J Cardiol; 2008 Jan; 123(2):138-46. PubMed ID: 17382417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.
    ; Ahmed A; Waagstein F; Pitt B; White M; Zannad F; Young JB; Rahimtoola SH
    Am J Cardiol; 2009 Jan; 103(1):82-7. PubMed ID: 19101235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction.
    Ahmed A; Aban IB; Weaver MT; Aronow WS; Fleg JL
    Eur J Heart Fail; 2006 Jun; 8(4):409-19. PubMed ID: 16311070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.
    Ahmed A; Rich MW; Love TE; Lloyd-Jones DM; Aban IB; Colucci WS; Adams KF; Gheorghiade M
    Eur Heart J; 2006 Jan; 27(2):178-86. PubMed ID: 16339157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure.
    Ahmed A; Gambassi G; Weaver MT; Young JB; Wehrmacher WH; Rich MW
    Am J Cardiol; 2007 Jul; 100(2):280-4. PubMed ID: 17631083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum digoxin concentration and outcomes in patients with heart failure.
    Rathore SS; Curtis JP; Wang Y; Bristow MR; Krumholz HM
    JAMA; 2003 Feb; 289(7):871-8. PubMed ID: 12588271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefits of low serum digoxin concentrations in heart failure.
    Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
    Ahmed A; Rich MW; Fleg JL; Zile MR; Young JB; Kitzman DW; Love TE; Aronow WS; Adams KF; Gheorghiade M
    Circulation; 2006 Aug; 114(5):397-403. PubMed ID: 16864724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
    Gheorghiade M; Patel K; Filippatos G; Anker SD; van Veldhuisen DJ; Cleland JG; Metra M; Aban IB; Greene SJ; Adams KF; McMurray JJ; Ahmed A
    Eur J Heart Fail; 2013 May; 15(5):551-9. PubMed ID: 23355060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study.
    Miura T; Kojima R; Mizutani M; Shiga Y; Takatsu F; Suzuki Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):77-83. PubMed ID: 11372597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
    Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.
    Hashim T; Elbaz S; Patel K; Morgan CJ; Fonarow GC; Fleg JL; McGwin G; Cutter GR; Allman RM; Prabhu SD; Zile MR; Bourge RC; Ahmed A
    Am J Med; 2014 Feb; 127(2):132-9. PubMed ID: 24067296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile.
    Adams KF; Ghali JK; Herbert Patterson J; Stough WG; Butler J; Bauman JL; Ventura HO; Sabbah H; Mackowiak JI; van Veldhuisen DJ
    Eur J Heart Fail; 2014 May; 16(5):483-93. PubMed ID: 24574198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.
    Adams KF; Butler J; Patterson JH; Gattis Stough W; Bauman JL; van Veldhuisen DJ; Schwartz TA; Sabbah H; Mackowiak JI; Ventura HO; Ghali JK
    Eur J Heart Fail; 2016 Aug; 18(8):1072-81. PubMed ID: 27492641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can available mathematical models predict serum digoxin levels in Thai patients?
    Jiratham-Opas J; Kanjanavanit R; Wongcharoen W; Punyawudho B; Arunmanakul P; Amaritakomol A; Topaiboon P; Gunaparn S; Phrommintikul A
    J Clin Pharm Ther; 2018 Jun; 43(3):377-384. PubMed ID: 29365353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of digoxin on mortality and morbidity in patients with heart failure.
    Digitalis Investigation Group
    N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study.
    Muk B; Vámos M; Bógyi P; Szabó B; Dékány M; Vágány D; Majoros Z; Borsányi T; Duray GZ; Kiss RG; Nyolczas N
    Clin Cardiol; 2020 Dec; 43(12):1641-1648. PubMed ID: 33140454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.